hong kong kangning pharmaceutical and chemical co., limited room 702 k owloon building555 nathan road kowl oon hong kongkowloon, , hong kong hong kong
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for hong kong kangning pharmaceutical and chemical co., limited room 702 k owloon building555 nathan road kowl oon hong kongkowloon, , hong kong hong kong from 2024 to 2025. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2025, the company has completed 1 transactions, with a transaction quantity of 5000 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2024 0 0 0
- 2025 1 5000 0
Bill of lading data
< 1/1 >- Trade date 2025/07/28 B/L No. 2272154
- Suppliers hong kong kangning pharmaceutical and chemical co., limited room 702 k owloon building555 nathan road kowl oon hong kongkowloon, , hong kong hong kong Buyers alivus life sciences limited
- POLs —— PODs jnpt
- Supply area China Purchas area India
- Weight —— Amount 441000
- Hs code 29329990 Product tags diiodo,hydroxybenzoyl,butyl,benzofuran
- Product description 2-BUTYL-3-(3,5-DIIODO-4-HYDROXYBENZOYL)BENZOFURAN 2-BUTYL-3-(3,5-DIIODO-4-HYDROXYBENZOYL)BENZOFURAN Expand
Partners
Total 1- Rank Company Transactions Per Detail
- 1 alivus life sciences limited indiabuyer,they trade on 2025-07-28 1 100.00% >
Products
Total 4- Products Transactions Per Detail
-
benzofuran
1 100% > -
butyl
1 100% > -
diiodo
1 100% > -
hydroxybenzoyl
1 100% >
Hscode rank
Total 1- HSCode Name Transactions Per Detail
- HS 29329990 1 100% >
Trading Area
Total 1- Area Transactions Per Detail
- india 1 100.00% >